> Puzzling Paradox of SSRI Induced Suicide
> Video: Andy Vickery explains the characteristics of antidepressant induced
> suicides
>
> http://www.justiceseekers.com/index.cfm/aol/1/MenuItemID/199/MenuGrou...
Wow that's entertaining. Is the price of Prozac going down---are
investors losing money?
> Puzzling Paradox of SSRI Induced Suicide
> Video: Andy Vickery explains the characteristics of antidepressant induced
> suicides
>
> http://www.justiceseekers.com/index.cfm/aol/1/MenuItemID/199/MenuGrou...
And the fact that a recent study shows these drugs work no better than
placebo has led NICE to ask for unpublished studies. # Jo Revill,
Whitehall editor
# The Observer,
# Sunday March 2 2008
http://www.guardian.co.uk/society/2008/mar/02/mentalhealth.medicalresearch
Drug firms pressed on secret pill data he big pharmaceutical companies
are to be 'shamed' into handing over their secret data on the effects
of antidepressant medications, amid growing concern that the 'sunshine
pills' may not work as well as originally promised.
A government minister has taken the unprecedented step of calling on
the drugs companies to give the data to the body that will review the
current depression guidelines, the National Institute for Health and
Clinical Excellence (Nice). Ivan Lewis, the minister with
responsibility for mental health, said that 'a failure to do so would
leave the inevitable impression they had something to hide'.
Nice, the body that looks at the effectiveness of all treatments and
recommends to the NHS how they should be used, is embarking on a fresh
look at the antidepressants known as selective serotonin reuptake
inhibitors, or SSRIs. Its most recent guidance was published four
years ago. However, the organisation has no legal right to see
unpublished data and can only request it from a company, which might
refuse to give it if the findings were negative.
Backed by the government, Nice is now set publicly to ask for all the
data, which would leave the companies facing huge criticism if they
did not hand it over. The toughening stance towards the companies
follows the publication last week of a major review that examined all
available data on the drugs, including trials that had not been
published.
It showed that antidepressants taken by millions of people worldwide
did not appear to work well - unless they were being given to the most
severely depressed patients. They found that when patients on the
drugs were compared with those who were taking a placebo they showed
similar rates of improvement.......
Thanks Vince